Current Neuro-Oncology

Volume 25 Number 9
15 May 2023

Home > Publications > Current Neuro-Oncology > Volume 25, Year 2023 > Number 9, 15 May

Sonabend AM, Gould A, Amidei C, Ward R, Schmidt KA, Zhang DY, Gomez C, Bebawy JF, Liu BP, Bouchoux G, Desseaux C, Helenowski IB, Lukas RV, Dixit K, Kumthekar P, Arrieta VA, Lesniak MS, Carpentier A, Zhang H, Muzzio M, Canney M, Stupp R.
Repeated blood-brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trial.
Lancet Oncol. 2023 May;24(5):509-522. doi: 10.1016/S1470-2045(23)00112-2. PMID: 37142373. Interventional study˰ ˍ

Das A, Tabori U, Sambira Nahum LC, Collins NB, Deyell R, Dvir R, Faure-Conter C, Hassall TE, Minturn JE, Edwards M, Brookes E, Bianchi V, Levine A, Stone SC, Sudhaman S, Sanchez-Ramirez S, Ercan AB, Stengs L, Chung J, Negm L, Getz G, Maruvka YE, Ertl-Wagner B, Ohashi PS, Pugh T, Hawkins C, Bouffet E, Morgenstern DA.
Efficacy of nivolumab in pediatric cancers with high mutation burden and mismatch-repair deficiency.
Clin Cancer Res. 2023 May 1:CCR-23-0411. doi: 10.1158/1078-0432.CCR-23-0411. PMID: 37126021. Interventional study. ˍ

Warren KE, Vezina G, Krailo M, Springer L, Buxton A, Peer CJ, Figg WD, William-Hughes C, Kessel S, Fouladi M, Gajjar A, Bowers D.
Phase II Randomized Trial of Lenalidomide in Children With Pilocytic Astrocytomas and Optic Pathway Gliomas: A Report From the Children's Oncology Group.
J Clin Oncol. 2023 May 1:JCO2201777. doi: 10.1200/JCO.22.01777. PMID: 37126770. Interventional study˰ ˍ

Wu X, Alvarez-Breckenridge C.
Moving the Pendulum for Glioblastoma Treatment: One Injection at a Time.
Oncologist. 2023 May 2:oyad104. doi: 10.1093/oncolo/oyad104. PMID: 37130338. Comment. ˍ
REFERS TO: Todo T, et al., Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial.
Nat Med. 2022 Jul 21
. doi: 10.1038/s41591-022-01897-x. PMID: 35864254. Interventional study. ˍ

Ho C, Malicki D, Levy M, Crawford JR.
Unusual pattern of metastatic disease in a patient in their early childhood with group 4 medulloblastoma.
BMJ Case Rep. 2023 May 4;16(5):e253877. doi: 10.1136/bcr-2022-253877. PMID: 37142287. Case report. ˍ

Jackson ER, Duchatel RJ, Staudt DE, Persson ML, Mannan A, Yadavilli S, Parackal S, Game S, Chong WC, Jayasekara WSN, Le Grand M, Kearney PS, Douglas AM, Findlay IJ, Germon ZP, McEwen HP, Beitaki TS, Patabendige A, Skerrett-Byrne DA, Nixon B, Smith ND, Day B, Manoharan N, Nagabushan S, Hansford JR, Govender D, McCowage GB, Firestein R, Howlett M, Endersby R, Gottardo NG, Alvaro F, Waszak SM, Larsen MR, Colino-Sanguino Y, Valdés-Mora F, Rakotomalala A, Meignan S, Pasquier E, Andre N, Hulleman E, Eisenstat DD, Vitanza NA, Nazarian J, Koschmann C, Mueller S, Cain JE, Dun MD.
ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma.
Cancer Res. 2023 May 5:CAN-23-0186. doi: 10.1158/0008-5472.CAN-23-0186. PMID: 37145169. Interventional study. ˍ

Burger MC, Forster MT, Romanski A, Straßheimer F, Macas J, Zeiner PS, Steidl E, Herkt S, Weber KJ, Schupp J, Lun JH, Strecker MI, Wlotzka K, Cakmak P, Opitz C, George R, Mildenberger IC, Nowakowska P, Zhang C, Röder J, Müller E, Ihrig K, Langen KJ, Rieger MA, Herrmann E, Bönig H, Harter PN, Reiss Y, Hattingen E, Rödel F, Plate KH, Tonn T, Senft C, Steinbach JP, Wels WS.
Intracranial injection of NK cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastoma.
Neuro Oncol. 2023 May 6:noad087. doi: 10.1093/neuonc/noad087. PMID: 37148198. Interventional study. ˍ

Neagu A, Niculae CM, Lăpădat I, Hristea A.
Challenges in the diagnosis of leptomeningeal dissemination of glioblastoma in a patient with fever and xanthochromic CSF: a case report.
Rom J Intern Med. 2023 May 6. doi: 10.2478/rjim-2023-0010. PMID: 37148304. Case report. ˍ

Sozer A, Borcek AO, Sagiroglu S, Poshtkouh A, Demirtas Z, Karaaslan MM, Kuzucu P, Celtikci E.
The first case of glioma detected by an artificial intelligence algorithm running on real-time data in neurosurgery: illustrative case.
J Neurosurg Case Lessons. 2023 May 8;5(19):CASE22536. doi: 10.3171/CASE22536? PMID: 37158388. Case report. ˍ

Zohdy YM, Agam M, Maldonado J, Jahangiri A, Pradilla G, Garzon-Muvdi T.
Symptomatic intracranial tumors in pregnancy: an updated management algorithm. Illustrative case.
J Neurosurg Case Lessons. 2023 May 8;5(19):CASE2399. doi: 10.3171/CASE2399? PMID: 37158391. Case report. ˍ

Alimohamadi M, Pour-Rashidi A, Larijani A, Rahmani M, Hendi K, Shariat Moharari R, Raminfard S, Ajam H, Gerganov V.
Perioperative seizure in patients undergoing brain mapping under awake craniotomy for language-related eloquent region gliomas: a prospective study.
J Neurosurg Sci. 2023 May 9. doi: 10.23736/S0390-5616.22.05675-2. PMID: 37158710. Interventional study˰ ˍ

Semeraro M, Fouquet C, Vial Y, Amiel J, Galmiche L, Cretolle C, Blanc T, Jolaine V, Garcelon N, Entz-Werle N, Pellier I, Vérité C, SophieTaque, Coulomb A, Petit A, Corradini N, Bouazza N, Lacour B, Clavel J, Brugières L, Bourdeaut F, Sarnacki S; members of the TED consortium.
Pediatric Tumors and Developmental Anomalies: A French Nationwide Cohort Study.
J Pediatr. 2023 May 9:113451. doi: 10.1016/j.jpeds.2023.113451. PMID: 37169337. Observational study˰ ˍ

Wang R, Cui J, Diao Y, Jin C, Chen Y, Lv X, Li X.
Risk factor analysis and nomogram establishment and verification of brain astrocytoma patients based on SEER database.
Sci Rep. 2023 May 12;13(1):7754. doi: 10.1038/s41598-023-33537-w. PMID: 37173353. Observational study. ˍ

Zilioli A, Misirocchi F, Mutti C, Pancaldi B, Mannini E, Spallazzi M, Parrino L, Cerasti D, Michiara M, Florindo I.
Volumetric hippocampal changes in glioblastoma: a biomarker for neuroplasticity?
J Neurooncol. 2023 May 13. doi: 10.1007/s11060-023-04315-5. PMID: 37178276. Observational study. ˍ